Planning and Evaluation supports the strategic planning of the Comprehensive Cancer Center of Wake Forest University (CCCWFU). Operations of the CCCWFU are entrusted to specific Boards and Committees, which serve as administrative """"""""planning and evaluation"""""""" units of the Center. The leadership of the CCCWFU uses both internal and external committees and boards to obtain substantive advice in order to continuously develop, modify, and evaluate the plans of the Center. Internal: Our internal meetings are an important part of developing the strategic direction for the Center and evaluating the performance. We convene standing meetings of the Internal Advisory Board, the Program Directors, the Shared Resource Directors, and clinical research oversight committees. In addition, each Program and Center of Excellence (as part of the Clinical Research Program) holds regularly scheduled meetings for their entire membership. External: We also are highly engaged with external boards and review groups. Our external Board of Scientific Councilors (BSC) has served the Cancer Center with leadership and insight and represents an essential element of independent review and external advice for the Cancer Center. The BSC meets yearly as a group to review the CCCWFU in its entirety, evaluating each Program within the broader context of the Center. In addition to this formal meeting, the Center Director, Dr. Frank Torti, and other members of the leadership team access Board members on many other occasions throughout the year. The individual research Programs also have external reviewers who provide feedback specific to the themes of the Programs and the plans for future directions. The full-day retreats are designed to give the reviewer in-depth information on the progress of research.

Public Health Relevance

The planning and evaluation component of our Center is the catalyst to enhance our cancer research and evaluate new opportunities. It is essential that we have our various internal and external committees and boards to ensure the trajectory of our scientific foci are delivering the highest quality scientific discoveries to enhance patient care, which is our ultimate goal.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Wake Forest University Health Sciences
United States
Zip Code
Feliz-Mosquea, Yismeilin R; Christensen, Ashley A; Wilson, Adam S et al. (2018) Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy. Breast Cancer Res Treat 172:69-82
Holmila, Reetta J; Vance, Stephen A; Chen, Xiaofei et al. (2018) Mitochondria-targeted Probes for Imaging Protein Sulfenylation. Sci Rep 8:6635
Rego, Stephen L; Harvey, Scott; Simpson, Sean R et al. (2018) TREX1 D18N mice fail to process erythroblast DNA resulting in inflammation and dysfunctional erythropoiesis. Autoimmunity :1-12
Li, X C; Wang, M Y; Yang, M et al. (2018) A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma. Ann Oncol 29:938-944
Lu, Yong; Wang, Qiang; Xue, Gang et al. (2018) Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors. Cancer Cell 33:1048-1060.e7
Godwin, Ryan C; Macnamara, Lindsay M; Alexander, Rebecca W et al. (2018) Structure and Dynamics of tRNAMet Containing Core Substitutions. ACS Omega 3:10668-10678
Peak, Taylor C; Praharaj, Prakash P; Panigrahi, Gati K et al. (2018) Exosomes secreted by placental stem cells selectively inhibit growth of aggressive prostate cancer cells. Biochem Biophys Res Commun 499:1004-1010
Akter, Salma; Fu, Ling; Jung, Youngeun et al. (2018) Chemical proteomics reveals new targets of cysteine sulfinic acid reductase. Nat Chem Biol 14:995-1004
Han, Fei; Li, Chien-Feng; Cai, Zhen et al. (2018) The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance. Nat Commun 9:4728
Chmielewski, Jeffrey P; Bowlby, Sarah C; Wheeler, Frances B et al. (2018) CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools. Mol Cancer Res 16:1687-1700

Showing the most recent 10 out of 548 publications